We examine how CMS F841 and new OIG oversight raise expectations for nursing home medical directors, demanding visible engagement, better policies, and data-informed leadership. We share field lessons on antipsychotics, facility assessment, and building dashboards that support real accountability.
• CMS shifts from F501 to F841 and clarifies medical director duties
• OIG focus on engagement, visit frequency, and compensation integrity
• Risks of absent or passive medical directors in daily care
• Antipsychotics oversight, diagnostic accuracy, and documentation alignment
• Hands-on leadership beyond QAPI with nursing and administration
• Facility assessment that reflects the real resident mix and needs
• Data and AI dashboards to drive timely, targeted action
• Contracts, coverage, and accountability that sustain engagement
We build on fall prevention and root cause analysis by asking compliance committees to take a deeper look at resident falls through targeted audits. We share two practical tools to guide record reviews, surface contributing factors, and strengthen a culture of safety and readiness across…
